Industry News
Test could identify which prostate cancers require treatment
Sep 16, 2013
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center... Read More
T-rays offer potential for earlier diagnosis of melanoma
Sep 16, 2013
The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist has said... Read More
Tiny diamonds to boost treatment of chemoresistant leukemia
Sep 16, 2013
By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer... Read More
New mutation identified, associated with better survival in lung cancer patients
Sep 16, 2013
Japanese researchers have identified a mutation associated with a higher incidence of lung cancer in Japanese women who do not smoke, but better survival in lung cancer patients... Read More
First randomized trial of targeted cancer medicine in all tumor types
Sep 16, 2013
A further step along the road to the personalisation of cancer medicine, where treatment is based on the individual molecular characteristics of tumours rather than their primary site, was presented at the 2013 European Cancer Congress (ECC2013), which started on Friday 27 September in Amsterdam, The Netherlands... Read More
Versatile microRNAs choke off cancer blood supply, suppress metastasis
Sep 15, 2013
A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report in Nature Communications... Read More
The protein Merlin "arranges" other protein interactions to control growth and prevent cancer
Sep 15, 2013
Johns Hopkins researchers have figured out the specific job of a protein long implicated in tumors of the nervous system. Reporting on a new study described in the Sept... Read More
Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence
Sep 15, 2013
A comparison of three methods of predicting the risk of recurrence in women treated for estrogen-receptor (ER)-positive breast cancer finds that only the breast cancer index (BCI) - a biomarker based on the expression levels of seven tumor-specific genes - accurately identifies patients who continue to be at risk after five years of treatment with either tamoxifen or the arom... Read More
Drug treatment means better, less costly care for children with sickle cell disease
Sep 15, 2013
The benefits of hydroxyurea treatment in people with sickle cell disease are well known - fewer painful episodes, fewer blood transfusions and fewer hospitalizations. Now new research from the Johns Hopkins Children's Center and other institutions reveals that by preventing such complications, the drug can also considerably lower the overall cost of medical care in children with this condition... Read More
Brachytherapy to treat cervical cancer declines in US, treatment associated with higher survival
Sep 14, 2013
A study by researchers at Brigham and Women's Hospital (BWH) found that brachytherapy treatment was associated with better cause-specific survival and overall survival in women with cervical cancer. The population-based analysis also revealed geographic disparities and decline in brachytherapy treatment in the United States... Read More
Previous Page Next Page
